Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Localized Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00003290
What this trial is testing

Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Medical Research Council 800
Testing effectiveness (Phase 2)WithdrawnNCT06881823
What this trial is testing

Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT01695473
What this trial is testing

Neoadjuvant BKM120 in High-risk Prostate Cancer

Who this might be right for
High Risk Prostate Cancer
Won Kim 11
Testing effectiveness (Phase 2)Study completedNCT02107430
What this trial is testing

Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
SOTIO a.s. 62
Testing effectiveness (Phase 2)Study completedNCT03081884
What this trial is testing

Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease

Who this might be right for
Cancer
Emory University 61
Not applicableLooking for participantsNCT06864533
What this trial is testing

Adjuvant Chemotherapy for High Malignant Prostate Cancer

Who this might be right for
Prostate CancerRadiation TherapyChemotherapy+1 more
Peking University First Hospital 315
Very early researchStudy completedNCT04301414
What this trial is testing

Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Columbia University 26
Not applicableEnded earlyNCT06375629
What this trial is testing

ES-HIFU, Prospective Data Collection of Patients Treated With Partial Gland HIFU Ablation for Prostate Cancer

Who this might be right for
Prostate Cancer
EDAP TMS S.A. 14
Testing effectiveness (Phase 2)Study completedNCT00561314
What this trial is testing

High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate CancerSexual DysfunctionUrinary Incontinence
University College London Hospitals 33
Large-scale testing (Phase 3)Study completedNCT00116142
What this trial is testing

Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 350
Testing effectiveness (Phase 2)Looking for participantsNCT05568550
What this trial is testing

Pembro With Radiation With or Without Olaparib

Who this might be right for
Prostate Cancer
Zin W Myint 64
Not applicableLooking for participantsNCT07343349
What this trial is testing

Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions

Who this might be right for
Prostate Cancer Patients Undergoing External Radiation and Seed ImplantationHigh Risk Localised Prostate CarcinomaLocally Advanced Prostate Cancer+1 more
Rigshospitalet, Denmark 1,016
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07796490
What this trial is testing

Neoadjuvant Intraprostatic OnabotulinumtoxinA Before Radical Prostatectomy for High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
The Methodist Hospital Research Institute 30
Testing effectiveness (Phase 2)Study completedNCT00500110
What this trial is testing

Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)Ended earlyNCT00860158
What this trial is testing

Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Noah Hahn, M.D. 1
Testing effectiveness (Phase 2)WithdrawnNCT03035357
What this trial is testing

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Who this might be right for
Malignant Neoplasms of Male Genital OrgansProstate Cancer
M.D. Anderson Cancer Center
Not applicableStudy completedNCT00318240
What this trial is testing

Prostate Cancer Treatment Following Radiation Failure With High Intensity Focused Ultrasound (HIFU)

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 40
Not applicableStudy completedNCT01686958
What this trial is testing

Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Profound Medical Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00193271
What this trial is testing

Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
SCRI Development Innovations, LLC 30
Testing effectiveness (Phase 2)Looking for participantsNCT07450599
What this trial is testing

Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.

Who this might be right for
High-risk Localized Prostate Cancer
Bayer 250
Next Page